CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System (OBDS), announced today that Sanofi is making a $30 million investment to accelerate Enable’s manufacturing build-out, strengthen its supply chain capabilities, and drive commercial growth. “This investment from one of our key partners shows support of the enFuse platform and our shared commitment to making large-volume subcutaneous ...